GHRP-2
D-alanyl-D-2-naphthylalanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide developed as a second-generation growth hormone secretagogue by Bowers and colleagues in the early 1990s. Also known as pralmorelin in clinical literature, it potently stimulates growth hormone release through GHS-R1a receptor activation. GHRP-2 incorporates D-amino acids for enhanced stability and resistance to enzymatic degradation, making it significantly more potent than earlier analogs like GHRP-6.
Complete Research Database
Growth Hormone Response Study
View StudyGrowth Hormone-Releasing Peptide-2 Stimulates Growth Hormone Release in Normal Men
PRIMARY RESULTS
8-12 fold increase in growth hormone within 30 minutes
KEY FINDINGS
- •Rapid and potent GH release
- •Dose-dependent response relationship
- •Well-tolerated with minimal side effects
Medical Disclaimer
GHRP-2 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.